Home › Lupus Nephritis › Massachusetts › Boston
Lupus Nephritis clinical trials in Boston, MA
7 studies for Lupus Nephritis are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
RecruitingPhase 2
- Brigham and Womens Hosp Harvard Med School, Boston
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
RecruitingPhase 1/2
- Research Site, Boston
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
RecruitingPhase 1
- Boston Medical Center, Boston
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
RecruitingPhase 1/2
- Tufts Medical Center, Boston
- Massachusetts General Hospital, Boston
- Boston Children's Hospital, Boston
- and 1 more
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
RecruitingPhase 1
- Brigham And Womens Hospital, Boston
Dapagliflozin in Active Lupus Nephritis
RecruitingPhase 4
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
Lupus Landmark Study: A Prospective Registry and Biorepository
RecruitingObservational study
- Brigham and Women's Hospital, Boston
Lupus Nephritis trials in other cities
- New York City, NY10 studies
- Chicago, IL9 studies
- Atlanta, GA9 studies
- Houston, TX8 studies
- Durham, NC8 studies
- Philadelphia, PA7 studies
- San Francisco, CA7 studies
- Aurora, CO5 studies
- St. Louis, MO5 studies
- Miami, FL5 studies
- Los Angeles, CA4 studies
- Cleveland, OH4 studies
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.